Author:
Martín-Mola Emilio,Plasencia-Rodríguez Chamaida
Publisher
Springer International Publishing
Reference88 articles.
1. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46(9):2287–93.
2. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387–93.
3. Winthrop K. Infections and biologic therapy in rheumatoid arthritis. In: Hochberg MC, Gravallese E, Silman A, Smolen JS, Weinblatt ME, Weisman M, editors. Rheumatology. 7th ed. Philadelphia: Elsevier; 2018. p. 608–14.
4. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007;66(10):1339–44.
5. Wallis D. Infection risk and biologics: current update. Curr Opin Rheumatol. 2014;26(4):404–9.